{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-26-254590","form_type":"8-K","ticker":"RGNX","cik":"0001590877","company_name":"REGENXBIO Inc.","filed_at":"2026-06-03T11:30:16+00:00","discovered_at":"2026-06-03T11:35:00.284955+00:00","generated_at":"2026-06-03T11:35:19.617842+00:00","sec_items":["5.07","8.01"],"event_type":"other_material","sentiment":"negative","materiality_score":0.35,"calibrated_materiality_score":0.35,"confidence":"high","headline":"REGENXBIO shareholders reject executive stock option exchange; approve non-executive program","bullets":["At 2026 annual meeting, shareholders voted against executive stock option exchange: 21,021,531 against, 14,097,815 for.","Shareholders approved non-executive stock option exchange: 26,352,456 for, 8,853,230 against. Company commenced program on June 3.","Exchange offer runs June 3–July 1, 2026; eligible options must have exercise price ≥ $18.00.","Directors elected: Jean Bennett, Jerry Karabelas, Daniel Tassé; PwC ratified as auditor; advisory say-on-pay approved.","Program not expected to significantly change stock compensation expense."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-26-254590","json":"https://secwatch.observer/filing/0001193125-26-254590.json","markdown":"https://secwatch.observer/filing/0001193125-26-254590.md","text":"https://secwatch.observer/filing/0001193125-26-254590.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1590877/000119312526254590/0001193125-26-254590-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1590877/000119312526254590/rgnx-20260529.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-03T11:35:19.617842+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"40f98da7f1142e24fc41779345cefe2371bcd554","claim":"REGENXBIO Inc. shareholders approved Ratification of appointment of PricewaterhouseCoopers LLP as independent registered public accounting firm for year ending December 31, 2026 at the 2026-05-29 meeting.","evidence_excerpt":"Proposal 2 : By the following vote, the stockholders ratified the appointment of PricewaterhouseCoopers LLP as the Company’s independent registered public accounting firm for the year ending December 31, 2026: Votes For Votes Against Votes Abstaining Broker Non-Votes 42,526,553 244,785 47,545 0","evidence_source":"SEC 8-K Item 5.07","evidence_url":"https://www.sec.gov/Archives/edgar/data/1590877/000119312526254590/0001193125-26-254590-index.htm","confidence":0.9,"family_label":"Shareholder Votes","details":[{"label":"Proposal","value":"auditor ratification"},{"label":"Outcome","value":"passed"},{"label":"Meeting","value":"2026-05-29"}],"fact_type":"shareholder_vote"},{"claim_id":"72064c30e88b973e1723a310d8c34693ae374d1a","claim":"REGENXBIO Inc. shareholders approved Advisory vote to approve compensation of named executive officers at the 2026-05-29 meeting.","evidence_excerpt":"Proposal 3 : By the following vote, the stockholders approved, on an advisory basis, the compensation of the Company’s named executive officers, as disclosed in the Proxy Statement: Votes For Votes Against Votes Abstaining Broker Non-Votes 32,392,302 2,722,825 149,635 7,554,121","evidence_source":"SEC 8-K Item 5.07","evidence_url":"https://www.sec.gov/Archives/edgar/data/1590877/000119312526254590/0001193125-26-254590-index.htm","confidence":0.9,"family_label":"Shareholder Votes","details":[{"label":"Proposal","value":"say on pay"},{"label":"Outcome","value":"passed"},{"label":"Meeting","value":"2026-05-29"}],"fact_type":"shareholder_vote"},{"claim_id":"81a9944e02c4d970ebb721f5e17475b6cdcdabdc","claim":"REGENXBIO Inc. shareholders approved Election of three Class II directors at the 2026-05-29 meeting.","evidence_excerpt":"Proposal 1 : By the following vote, the following three persons were elected to serve as Class II directors until the Company’s 2029 annual meeting of stockholders: Nominee Votes For Votes Withheld Broker Non-Votes Jean Bennett, M.D., Ph.D. 24,025,836 11,238,926 7,554,121 A.N. “Jerry” Karabelas, Ph.D. 27,124,923 8,139,839 7,554,121 Daniel Tassé 32,039,753 3,225,009 7,554,121","evidence_source":"SEC 8-K Item 5.07","evidence_url":"https://www.sec.gov/Archives/edgar/data/1590877/000119312526254590/0001193125-26-254590-index.htm","confidence":0.9,"family_label":"Shareholder Votes","details":[{"label":"Proposal","value":"director election"},{"label":"Outcome","value":"passed"},{"label":"Meeting","value":"2026-05-29"}],"fact_type":"shareholder_vote"},{"claim_id":"be6dd6ece7801cb88fa6c7c74ba1917d88bd8c32","claim":"REGENXBIO Inc. shareholders approved Approval of Stock Option Exchange Program for non-executive employees at the 2026-05-29 meeting.","evidence_excerpt":"Proposal 4 : By the following vote, the stockholders approved, the Stock Option Exchange Program for the Company’s non-executive employees: Votes For Votes Against Votes Abstaining Broker Non-Votes 26,352,456 8,853,230 59,076 7,554,121","evidence_source":"SEC 8-K Item 5.07","evidence_url":"https://www.sec.gov/Archives/edgar/data/1590877/000119312526254590/0001193125-26-254590-index.htm","confidence":0.9,"family_label":"Shareholder Votes","details":[{"label":"Proposal","value":"equity plan"},{"label":"Outcome","value":"passed"},{"label":"Meeting","value":"2026-05-29"}],"fact_type":"shareholder_vote"},{"claim_id":"d4ec1a0d3d9225735a3fd8416ab1c2d33a39acd4","claim":"REGENXBIO Inc. shareholders rejected Stock Option Exchange Program for executive employees at the 2026-05-29 meeting.","evidence_excerpt":"Proposal 5 : By the following vote, the stockholders did not approve, a Stock Option Exchange Program for the Company’s executive employees: Votes For Votes Against Votes Abstaining Broker Non-Votes 14,097,815 21,021,531 145,416 7,554,121","evidence_source":"SEC 8-K Item 5.07","evidence_url":"https://www.sec.gov/Archives/edgar/data/1590877/000119312526254590/0001193125-26-254590-index.htm","confidence":0.9,"family_label":"Shareholder Votes","details":[{"label":"Outcome","value":"failed"},{"label":"Meeting","value":"2026-05-29"}],"fact_type":"shareholder_vote"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}